Sacroiliac joint syndrome is the cause of musculoskeletal back pain

The article considers a clinical case of treatment of one of the variants of nonspecific back pain – sacroiliac joint syndrome.   In this case, we tried to demonstrate the importance of timely and accurate determination of the cause of dorsalgia using currently available tools: medical scales, X-ray and MRI examination, diagnostic drug blockade of the pain zone. A scrupulous analysis of complaints, anamnesis and clinical manifestations of the patient, a differential diagnosis with a number of diseases with a similar clinical picture, as well as the choice of treatment tactics based on federal clinical recommendations for the treatment of patients with nonspecific back pain made it possible to quickly determine the diagnosis and cope with the pain syndrome. Therapy with the inclusion of medications, physiotherapy, manual therapy, post-isometric relaxation, physical therapy, posture correction allowed the patient to stop the pain syndrome and return to an active lifestyle. Dexketoprofen (Dexalgin®) was prescribed to relieve the pain syndrome. Optimization of the method of administration of the drug is a step-by-step scheme for prescribing dexketoprofen: parenteral administration of 2 injections (50 mg) intramuscularly daily for 2 days, then transfer to oral Dexalgin intake – 25 mg 2 times a day for 3 days under the guise of proton pump inhibitors – Esomeprazole 40 mg 1 time a day, the use of a patch with a local anesthetic, vitamins of group B – 12 days, therapeutic and diagnostic drug blockades – contributed to a significant reduction in the intensity of the pain syndrome and allowed to prevent its transformation into a chronic process. As a result of the use of complex, pathogenetically based therapy, a rapid positive therapeutic effect was achieved.

1. Varavin NA, Vertkin А.L. Back pain in therapeutic practice. Lechaschi Vrach. 2022;25(7-8):52–56. (In Russ.) https://doi.org/10.51793/OS.2022.25.8.008.

2. Parfenov VA, Yakhno NN, Kukushkin ML, Churyukanov MV, Davydov OS, Golovacheva VA et al. Acute nonspecific (musculoskeletal) low back pain. Guidelines of the Russian Society for the Study of Pain (RSSP). Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2):4–11. (In Russ.) https://doi.org/10.14412/2074-2711-2018-2-4-11.

3. Amelin AV, Balyazin VA, Davydov OS, Zyryanov SK, Kiselev DV, Kurushina OV et al. Russian multicenter study of fixed combination of diclofenac and orphenadrine its efficacy and tolerance of in acute non-specific pain and radiculopathy relief. Russian Journal of Pain. 2022;20(1):33–41. (In Russ.) https://doi.org/10.17116/pain20222001133.

4. Allegri M, Montella S, Salici F, Valente A, Marchesini M, Compagnone C et al. Mechanisms of low back pain: a guide for diagnosis and. F1000Res. 2016; 5(F1000 Faculty Rev):1530. https://doi.org/10.12688/f1000research.8105.2.

5. Vyshlova IA, Karpov SM, Raevskaya AI, Reverchuk IV. Rehabilitation of patients with chronic low back pain. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2022;122(6):14–19. (In Russ.) https://doi.org/10.17116/jnevro202212206114.

6. Isaykin AI, Kuznetsov IV, Kavelina AV, Ivanova MA. Facet syndrome: causes, clinical features, diagnosis and treatment. Consilium Medicum. 2016;18(2):53–61. (In Russ.) Available at: https://cyberleninka.ru/article/n/fasetochnyy-sindrom-prichiny-vozniknoveniya-klinika-diagnostika-i-lechenie.

7. Hooten WM, Cohen SP. Evaluation and Treatment of Low Back Pain: A Clinically Focused Review for Primary Care Specialists. Mayo Clin Proc. 2015;90(12):1699–1718. https://doi.org/10.1016/j.mayocp.2015.10.009.

8. Isaykin AI, Ivanova MA, Kavelina AV, Chernenko OA, Yakhno NN. Sacroiliac joint dysfunction. RMJ. 2016;24:1583–1588. (In Russ.) Available at: https://www.rmj.ru/articles/nevrologiya/Sindrom_krestcovo-podvzdoshnogo_sochleneniya/.

9. King W, Ahmed SU, Baisden J, Patel N, Kennedy DJ, Duszynski B, MacVicar J. Diagnosis and treatment of posterior sacroiliac complex pain: A systematic review with comprehensive analysis of the published data. Pain Medicine. 2015;16(2):257–265. https://doi.org/10.1111/pme.12630.

10. Fortin JD Aprill CN, Ponthieux B, Pier J. Sacroiliac joint: pain referral maps upon applying a new injection/arthrography technique: part II: clinical evaluation. Spine. 1994;19(13):1483–1489. Available at: https://pubmed.ncbi.nlm.nih.gov/7939979/.

11. Vleeming A, Pool-Goudzwaard AL, Hammudoghlu D, Stoeckart R, Snijders CJ, Mens JM. The function of the long dorsal sacroiliac ligament: its implication for understanding low back pain. Spine. 1996;21(5):556–562. https://doi.org/10.1097/00007632-199603010-00005.

12. Vleeming A, de Vries HJ, Mens JM, van Wingerden JP. Possible role of the long dorsal sacroiliac ligament in women with peripartum pelvic pain. Acta Obstet Gynecol Scand. 2002;81(5):430–436. https://doi.org/10.1034/j.1600-0412.2002.810510.x.

13. Ronchetti I, Vleeming A, van Wingerden JP. Physical characteristics of women with severe pelvic girdle pain after pregnancy: a descriptive cohort study. Spine. 2008;33(5):145–151. https://doi.org/10.1097/BRS.0b013e3181657f03.

14. Isaykin AI, Ivanova MA, Kavelina AV, Shevtsova GYe. Dysfunction of the Sacroiliac Joint. Effective Pharmacotherapy. 2017;(21):13–16. (In Russ.) Available at: https://umedp.ru/upload/iblock/f5e/dolgit.pdf.

15. Akhmetov BH, Maximov YN. Role of pathology the sacroiliac joint in the development of pain in the lower back. Practical Medicine. 2013;(1):27–30. (In Russ.) Available at: https://cyberleninka.ru/article/n/rol-patologii-kresttsovo-podvzdoshnogo-sustava-v-razvitii-boley-v-nizhney-chasti-spiny.

16. Yarikov AV, Morev AV, Shpagin MV, Fryerman AP. Sacroiliac joint syndrome: aetiology, clinical presentation, diagnosis and management. Annals of Clinical and Experimental Neurology. 2019;13(2):60–68. (In Russ.) https://doi.org/10.25692/ACEN.2019.2.7.

17. Dreyfuss P, Michaelsen M, Pauza K, McLarty J, Bogduk N. The value of medical history and physical examination in diagnosing sacroiliac joint pain. Spine. 1996;21(22):2594–2602. https://doi.org/10.1097/00007632-199611150-00009.

18. Slipman CW, Sterenfeld EB, Chou LH, Herzog R, Vresilovic E. The predictive value of provocative sacroiliac joint stress maneuvers in the diagnosis of sacroiliac joint syndrome. Arch Phys Med Rehabil. 1998;79(3):288–292. https://doi.org/10.1016/s0003-9993(98)90008-9.

19. Laslett M, Aprill C, McDonald B, Young S. Diagnosis of sacroiliac joint pain: validity of individual provocation tests and composites of tests. Man Ther. 2005;10(3):207–218. https://doi.org/10.1016/j.math.2005.01.003.

20. Van der Wurff P, Buijs EJ, Groen GJ. A multitest regimen of pain provocation tests as an aid to reduce unnecessary minimally invasive sacroiliac joint procedures. Arch Phys Med Rehabil. 2006;87(1):10–14. https://doi.org/10.1016/j.apmr.2005.09.023.

21. Broadhurst NA, Bond MJ. Pain provocation tests for the assessment of sacroiliac joint dysfunction. J Spinal Disord. 1998;11(4):341–345. Available at: https://pubmed.ncbi.nlm.nih.gov/9726305/.

22. Szadek KM, van der Wurff P, van Tulder MW, Zuurmond WW, Perez RS. Diagnostic validity of criteria for sacroiliac joint pain: a systematic review. J Pain. 2009;10(4):354–368. https://doi.org/10.1016/j.jpain.2008.09.014.

23. Kokmeyer DJ, van der Wurff P, Aufdemkampe G, Fickenscher T. The reliability of multitest regimens with sacroiliac pain provocation tests. J Manipulative Physio Ther. 2002;25(1):42–48. https://doi.org/10.1067/mmt.2002.120418.

24. Prather H, Hunt D. Conservative management of low back pain, part I. Sacroiliac joint pain. Dis Mon. 2004;50(12):670–683. https://doi.org/10.1016/j.disamonth.2004.12.004.

25. Vleeming A, Schuenke MD, Masi AT, Carreiro JE, Danneels L,Willard FH. The sacroiliac joint: an overview of its anatomy, function and potential clinical implications. J Anat. 2012;221(6):537–567. https://doi.org/10.1111/-j.1469-7580.2012.01564.x.

26. Young S, Aprill C, Laslett M. Correlation of clinical examination characteristics with three sources of chronic low back pain. Spine J. 2003;3(6):460–465. https://doi.org/10.1016/s1529-9430(03)00151-7.

27. Poley RE, Borchers JR. Sacroiliac joint dysfunction: evaluation and treatment. Phys Sportsmed. 2008;36(1):42–49. https://doi.org/10.3810/psm.2008.12.10.

28. Shavlovskaya OA, Gordeeva IE, Ansarov KSh, Prokofyeva YuS, Chronic pain syndrome in diseases of periarticular tissues. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(3):109–118. (In Russ.) https://doi.org/10.17116/jnevro2020120031109.

29. Buchanan P, Vodapally S, Lee DW, Hagedorn JM, Bovinet C, Strand N et al. Successful diagnosis of sacroiliac joint dysfunction. J Pain Res. 2021(14):3135–3143. https://doi.org/10.2147/JPR.S327351.

30. Chou R, Huffman LH. Medications for Acute and Chronic Low Back Pain: A Review of the Evidence for an American Pain Society/American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2007;147(7):505–514. https://doi.org/10.7326/0003-4819-147-7-200710020-00008.

31. van Tulder M, Becker A, Bekkering T, Breen A, del Real MT, Hutchinson A et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J. 2006;15(Suppl. 2):169–191. https://doi.org/10.1007/s00586-006-1071-2.

32. Puhakka KB, Jurik AG, Schiøttz-Christensen B, Hansen GV, Egund N, Christiansen JV, Stengaard-Pedersen K. MRI abnormalities of sacroiliac joints in early spondylarthropathy: a 1‐year follow‐up study. Scand J Rheumatol. 2004;33(5):332–338. https://doi.org/10.1080/03009740410005881.

33. Kukushkin ML. Diagnosis and treatment of nonspecific back pain. Meditsinskiy Sovet . 2016;(8):58–63. (In Russ.) https://doi.org/10.21518/2079-701X-2016-8-58-63.

34. Подчуфарова ЕВ, Яхно НН. Боль в спине. М: ГЭОТАР-Медиа. 2013;368. Режим доступа: https://www.rosmedlib.ru/book/ISBN9785970424742.html.

35. Elgafy H, Semaan H, Ebraheim N, Coombs R. Computed tomography findings in patients with sacroiliac pain. Clin Orthop Relat Res. 2001;382:112–118. https://doi.org/10.1097/00003086-200101000-00017.

36. Slipman CW, Sterenfeld EB, Chou LH, Herzog R, Vresilovic E. The value of radionuclide imaging in the diagnosis of sacroiliac joint syndrome. Spine. 1996;21(19):2251–2254. https://doi.org/10.1097/00007632-199610010-00013.

37. Isaikin AI, Kavelina AV, Shor YuM, Merbaum PA, Shadyzheva TI. Sacroiliac joint dysfunction: clinical presentations, diagnosis, treatment. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(2):62–68 (In Russ.) https://doi.org/10.14412/2074-2711-2019-2S-62-68.

38. Парфенов ВА, Исайкин АИ. Боль в нижней части спины: мифы и реальность. М.: ИМА-ПРЕСС; 2016. 104 с. Режим доступа: https://nnp.ima-press.net/nnp/article/view/842/733.

39. Kennedy DJ, Engel A, Kreiner DS, Nampiaparampil D, Duszynski B, MacVicar J. Fluoroscopically guided diagnostic and therapeutic intraarticular sacroiliac joint injections. Pain Med. 2015;16(8):1500–1518. https://doi.org/10.1111/pme.12833.

40. Polly D, Cher D, Whang PG, Frank C, Sembrano J, INSITE Study Group. Does level of response to SI joint block predict response to SI joint fusion? Int J Spine Surg. 2016;10(4). https://doi.org/10.14444/3004.

41. Isaikin AI, Kuznetsov IV, Kavelina AV, Ivanova MA. Nonspecific low back pain: Causes, clinical picture, diagnosis, and treatment. Neurology, Neuropsychiatry, Psychosomatics. 2015;7(4):101–109. https://doi.org/10.14412/2074-2711-2015-4-101-109.

42. Алексеев АВ, Аринина ЕЕ, Арсеньев АО, Баринов АН, Бранд ПЯ, Власов ВВ и др. Неспецифическая боль в нижней части спины. М: КомплексСервис; 2008.

43. Ignatova AV. Experience of using the drug Chondrogard as part of therapeutic drug blockades in the treatment of facet syndrome and dysfunction of the sacroiliac joint in an outpatient setting. RMJ. 2013;(21):524–526. (In Russ.) Available at: https://www.rmj.ru/articles/nevrologiya/Opyt_primeneniya_preparata_Hondrogard_v_sostave_lechebno-medikamentoznyh_blokad_v_lechenii_fasetochnogo_sindroma_i_disfunkcii_krestcovo-podvzdoshnogo_sochleneniya_v_ambulatornyh_usloviyah/.

44. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F et al. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15 (Suppl. 2):192–300. https://doi.org/10.1007/s00586-006-1072-1.

45. Chou R. Low back pain (chronic). BMJ Clin Evid. 2010;(2010):1116. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217809/.

46. Kаssis А. Antidepressants to treat nonspecific low back pain. Am Fam Physician. 2008;78(1):51–52. Available at: https://www.aafp.org/pubs/afp/issues/2008/0701/p51.html.

47. Prodan AI, Sirenko AA, Kolesnichenko VA. Spinal facet joint denervation: pro et contra. Hirurgia Pozvonochnika. 2005;(3):78–86. (In Russ.) https://doi.org/10.14531/ss2005.3.78-86.

48. Isaykin AI, Davydov OS, Kavelina AV, Ivanova MA. Problem of Spondylosis. The Neurologist’s Point of View. Effective Pharmacotherapy. 2017(38):28–41. (In Russ.) Available at: https://umedp.ru/articles/problema_spondiloartroza_vzglyad_nevrologa.html.

49. Kavelina AV, Isaikin AI, Ivanova MA. Interventional medicine techniques in the treatment of nonspecific low back pain caused by sacroiliac joint dysfunction. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(2):33–37. (In Russ.) https://doi.org/10.14412/2074-2711-2018-2-33-37.

50. van Tulder M, Becker A, Bekkering T, Breen A, del Real MT, Hutchinson A et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J. 2006;15(Suppl 2):169–191. https://doi.org/10.1007/s00586-006-1071-2.

51. Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478–491. https://doi.org/10.7326/0003-4819-147-7-200710020-00006.

52. Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Andersen M et al. National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2018;27(1):60–75. https://doi.org/10.1007/s00586-017-5099-2.

53. Steffens D, Maher CG, Pereira LS, Stevens ML, Oliveira VC, Chapple M et al. Prevention of Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med. 2016;176(2):199–208. https://doi.org/10.1001/jamainternmed.2015.7431.

54. Itz CJ, Willems PC, Zeilstra DJ, Huygen FJ et al. Dutch multidisciplinary guideline for invasive treatment of pain syndromes of the lumbosacral spine. Pain Pract. 2016;16(1):90–110. https://doi.org/10.1111/papr.12318.

55. Samartsev IN, Zhivolupov SA, Trofimov EA, Shostak MS, Balbert AA, Parshin MS. Interdisciplinary Consensus on the Local Use of Glucocorticoids in Actual Clinical Practice. Nervous Diseases. 2021;(4):74-84. (In Russ.) https://doi.org/10.24412/2226-0757-2021-12381.

56. Roy IV, Fishchenko YaV, Kudrin AP. Radiofrequency neuroablation of the sacroiliac joint as a method of treating pain syndrome. Trauma. 2017;(18):95–99. (In Russ.) https://doi.org/10.22141/1608-1706.2.18.2017.102565.

57. Fishchenko Y, Kudrin A, Kravchuk L. Radiofrequency neuroablation in the treatment of pain syndrome of the sacroiliac joint. Pain, joints, spine. 2018;8(2):80–84. (In Russ.) Available at: https://cyberleninka.ru/article/n/radiochastotnaya-neyroablyatsiya-v-lechenii-bolevogo-sindroma-kresttsovo-podvzdoshnogo-sustava.

58. Evzikov GYu, Egorov OE, Rozen AI. Radiofrequency denervation in the treatment of pain syndrome because of sacroiliac joint pathology. Russian Journal of Neurosurgery. 2015;(2):80–85. (In Russ.) Available at: https://www.therjn.com/jour/article/view/169#.

59. Rashbaum RF, Ohnmeiss DD, Lindley EM, Kitchel SH, Patel VV. Sacroiliac joint pain and its treatment. Clin Spine Surg. 2016;29(2):42–48. https://doi.org/10.1097/BSD.0000000000000359.

60. Polly DW, Swofford J, Whang PG, Frank CJ, Glaser JA, Limoni RP et al. Two-year outcomes from a randomized controlled trial of minimally invasive sacroiliac joint fusion vs. non-surgical management for sacroiliac joint dysfunction. Int J Spine Surg. 2016;10:28. https://doi.org/10.14444/3028.

61. Zaidi H, Montoure A, Dickman C. Surgical and clinical efficacy of sacroiliac joint fusion: a systematic review of the literature. J Neurosurg Spine. 2015;23(1):59–66. https://doi.org/10.3171/2014.10.SPINE14516.

62. Lingutla KK, Pollock R, Ahuja S. Sacroiliac joint fusion for low back pain: a systematic review and meta-analysis. Eur Spine J. 2016;25(6):1924–1931. https://doi.org/10.1007/s00586-016-4490-8.

63. Carabaza A, Suesa N, Tost D, Pascual J, Gomez M, Gutierrez M et al. Stereoselective metabolic pathways of ketoprofen in the rat: incorporation into triacylglycerols and enantiomeric inversion. Chirality. 1996;8(2):163–172. https://doi.org/10.1002/(SICI)1520-636X(1996)8:23.0.CO;2-K.

64. Hayball PJ, Nation RL, Bochner F. Enantioselective pharmacodynamics of the non-steroidal antiinflammatory drug ketoprofen: In vitro inhibition of human platelet cyclooxygenase activity. Chirality. 1992;4(8):484–487. https://doi.org/10.1002/chir.530040805.

65. Suesa N, Fernández MF, Gutiérrez M, Rufat MJ, Rotllán E, Calvo L et al. Stereoselective cyclooxygenase inhibition in cellular models by the enatiomers of ketoprofen. Chirality. 1993;5(8):589–595. https://doi.org/10.1002/chir.530050805.

66. Pilipovich AA. Dexketoprofen: therapeutic potential in neurology. Consilium Medicum. 2018;20(9):71–75. (In Russ.) Available at: https://cyberleninka.ru/article/n/deksketoprofen-vozmozhnosti-primeneniya-v-nevrologii.

67. Metscher B, Kübler U, Jahnel-Kracht H. Dexketoprofen-trometamol and tramadol in acute lumbago. Fortschr Med Orig. 2000;118(4):147–151. Available at: https://pubmed.ncbi.nlm.nih.gov/11217678/.

68. Zippel H, Wagenitz A. Comparison of the efficacy and safety of intravenously administered dexketoprofen trometamol and ketoprofen in the management of pain after orthopaedic surgery: a multicentre, doubleblind, randomised, parallel-group clinical trial. Clin Drug Investig. 2006;26(9):517–528. https://doi.org/10.2165/00044011-200626090-00005.

69. Laporte J-R, Ibanez L, Vidal X, Vendrell L, Leone R. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Safety. 2004;27(6):411–420. https://doi.org/10.2165/00002018-200427060-00005.

70. López-Muñoz FJ, Ventura R, Díaz I, Fernández-Guasti A, Tost D, Cabré F, Mauleón D. Antinociceptive effects of S(+)-ketoprofen and other analgesic drugs in a rat model of pain induced by uric acid. J Clin Pharmacol. 1998;38:11S-21S. https://doi.org/10.1002/jcph.1998.38.s1.11.

71. Carabaza A, Cabré F, García AM, Rotllan E, García ML, Mauleón D. Stereoselective inhibition of rat brai cyclooxygenase by dexketoprofen. Chirality. 1997;9(3):281–285. https://doi.org/10.1002/(SICI)1520-636X(1997)9:33.0.CO;2-J.

72. Mazario J, Roza C, Herrero JF. The NSAID dexketoprofen trometamol is as potent as μ-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats. Brain Research. 1999;816(2):512–517. https://doi.org/10.1016/S0006-8993(98)01203-7.